Activist 13D/13G Filings - Nabriva Therapeutics plc (NBRV)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2022-02-09
09:22 am
Purchase		13GNABRIVA THERAPEUTICS PLC
NBRV		FMR LLC2,215,958
3.847%		786,699increase
(+55.04%)		View
2021-11-19
12:57 pm
Purchase		13GNABRIVA THERAPEUTICS PLC
NBRV		Lincoln Park Capital Fund LLC4,512,589
7.96%		4,512,589increase
(New Position)		View
2021-02-08
10:35 am
Purchase		13GNABRIVA THERAPEUTICS PLC
NBRV		FMR LLC1,429,259
6.78%		1,429,259increase
(New Position)		View
2020-02-12
4:32 pm
Purchase		13GNABRIVA THERAPEUTICS PLC
NBRV		Longitude Capital Partners II LLC4,256,527
4.5%		244,152increase
(+6.08%)		View
2020-02-07
11:26 am
Purchase		13GNABRIVA THERAPEUTICS PLC
NBRV		FMR LLC6,131,900
6.485%		6,131,900increase
(New Position)		View
2019-12-26
4:01 pm
Unchanged		13DNABRIVA THERAPEUTICS AG
NBRV		ORBIMED ADVISORS LLC4,644,600
4.9%		0
(Unchanged)		View
2019-12-06
4:46 pm
Unchanged		13DNABRIVA THERAPEUTICS AG
NBRV		ORBIMED ADVISORS LLC4,644,600
5.9%		0
(Unchanged)		View
2019-08-14
4:31 pm
Sale		13GNABRIVA THERAPEUTICS PLC
NBRV		Vivo Capital VIII LLC3,528,566
4.8%		-1,272,767decrease
(-26.51%)		View
2019-07-01
4:52 pm
Sale		13GNABRIVA THERAPEUTICS AG
NBRV		Novo Holdings A/S3,446,564
4.74%		-1,257,156decrease
(-26.73%)		View